When do side effects from Mounjaro tend to show up?

The first week: your body meeting tirzepatide

Picture the moment the plain, unbranded box arrives via DPD tracked delivery. Inside is your Mounjaro KwikPen, pre-filled and ready. Most people do their first injection that evening, and by the following morning is typically when any side effects make themselves known. Nausea is the main one. It can range from a mild background queasiness to something that makes eating feel unappealing, and it often peaks around 24–72 hours after the injection before beginning to ease.

The reason this happens is rooted in how tirzepatide works: it activates both GIP and GLP-1 receptors, slowing gastric emptying and signalling fullness to the brain. Your gut is adapting to a new rhythm. Eating smaller portions, keeping food bland for the first day or two, and staying well hydrated all help. The full Mounjaro side effects guide covers practical coping strategies in more detail.

Fatigue, headache and some dizziness are also reported in the first week, again usually settling as the week progresses. Injection-site redness or mild soreness is common too, rotating between the abdomen, thigh and upper arm from the outset reduces this. For most people, the first week is the worst of it at the 2.5mg starting dose. That first dose is deliberately gentle: its job is to let your system adjust, not to produce rapid change.

What happens when your dose goes up

A pattern tends to repeat with each dose increase. The onset of side effects after stepping up to 5mg, 7.5mg or higher follows a similar arc to week one, symptoms can resurface in the 24–72 hours after the new dose, then typically settle again. Some people find the step-ups easier than the start; others find a particular dose level takes a little longer to feel comfortable at.

This is exactly why Mounjaro's schedule moves in gradual steps rather than jumping straight to a higher dose. Your prescriber controls the pace. If a step-up causes side effects that feel unmanageable, the clinical answer is often to stay at the current dose a little longer rather than push on, that decision belongs with your prescriber, not a fixed calendar. A useful read on how the pattern unfolds is the timing breakdown for each dose change.

Constipation can become more prominent at higher doses. Increasing fluid intake and dietary fibre tends to help, and again, your prescriber or the Patient Information Leaflet inside your pen box is the right source for personal guidance.

When side effects ease, and when they don't

The honest picture is that for a large proportion of people, the GI effects associated with each dose settle within one to two weeks. How quickly side effects resolve varies between individuals, body weight, how quickly doses are titrated, and individual gut sensitivity all play a role. SURMOUNT-1, the large phase-3 trial of tirzepatide published in the New England Journal of Medicine, found nausea and diarrhoea were the most common reasons for discontinuation, though most participants completed the study.

A small number of people find that nausea persists beyond the adjustment period, or that it returns unpredictably. That warrants a conversation with your prescriber rather than pushing through. You can read more about the broader experience of Mounjaro side effects across the treatment period, including what people find genuinely helps.

Worth noting: side effects that ease at one dose often do not reappear at the same intensity once the body has fully adapted. Many people who struggled initially report a marked improvement by the second or third month. That said, everyone's experience is different, and the only person qualified to advise whether to continue or adjust your treatment is your prescriber.

When to get medical help urgently

Most Mounjaro side effects are unpleasant rather than dangerous. A handful are not. Seek urgent medical attention (call 111, your GP or 999 in an emergency) if you experience any of the following.

Severe stomach pain that doesn't pass, especially if it spreads toward your back and is accompanied by vomiting, may indicate pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines including tirzepatide, do not wait to see if it improves on its own.

Signs of a serious allergic reaction (swelling of the face, lips, tongue or throat, difficulty breathing, a widespread rash) also need emergency care. Severe vomiting or diarrhoea that leaves you unable to keep fluids down can cause dehydration that strains the kidneys; this too needs prompt assessment rather than home management.

Any unexpected low mood, thoughts of self-harm, or sudden changes in vision should be raised with a clinician promptly. These are rarer but real possibilities acknowledged in the prescribing information. If you're unsure whether what you're experiencing warrants a call, the answer is almost always: make the call. You can also report any suspected side effect to the MHRA Yellow Card scheme, it takes a few minutes and helps build the safety picture for everyone taking these medicines.

If you have questions about how Mounjaro side effects might affect you personally, our prescribers discuss this as part of the consultation at your free assessment. And if you're still exploring whether Mounjaro is the right option, the weight-loss treatments overview sets out the full picture.